Company / SG&A Expense
Elevance Health SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$21.0B
FY2025
5-year range
$13.4B / $21.0B
FY2021-FY2025
Trend
+4.8%
vs FY2024
Sector context
#3 of 158
Health Care
What the data says
Among 158 Health Care companies, Elevance Health is in the bottom 2% for sg&a expense. SG&A Expense has fluctuated over the past 10 years, ranging from $12.6B in FY2016 to $21.0B in FY2025.
Based on SEC 10-K filings.
$21.0B in FY2025 with a 5-year CAGR of +3.8%. Ranks 3rd among 158 companies in Health Care.
Increased from $15.9B to $21.0B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +5.8%
- 5-Year CAGR
- +3.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 158This company $21.0B Sector average $175.9B
▼
-88.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.8%, indicating consistent growth.
- In FY2025, sg&a expense increased 4.8% year-over-year.
- Ranks #3 out of 158 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2016.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.0B | +4.8% |
| FY2024 | $20.0B | +25.8% |
| FY2023 | $15.9B | -10.1% |
| FY2022 | $17.7B | +32.4% |
| FY2021 | $13.4B | -23.4% |
| FY2020 | $17.4B | +30.6% |
| FY2019 | $13.4B | -4.7% |
| FY2018 | $14.0B | +10.8% |
| FY2017 | $12.7B | +0.7% |
| FY2016 | $12.6B | +0.2% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026